Anzeige
Mehr »
Login
Freitag, 03.02.2023 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News! Startup wird zum Pionier!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CPJD ISIN: US0926671043 Ticker-Symbol:  
NASDAQ
02.02.23
22:00 Uhr
4,790 US-Dollar
0,000
0,00 %
Branche
Luftfahrt/Rüstung
Aktienmarkt
Sonstige
1-Jahres-Chart
BLADE AIR MOBILITY INC Chart 1 Jahr
5-Tage-Chart
BLADE AIR MOBILITY INC 5-Tage-Chart
GlobeNewswire (Europe)
413 Leser
Artikel bewerten:
(2)

Blade Air Mobility, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2022

  • Third quarter ended September 30, 2022 revenue up 125% versus the prior year period to $45.7 million; nine month period ended September 30, 2022 revenue up 154% versus the prior year period to $108.0 million
  • Short Distance revenue up 52% in Q3 2022 versus the prior year period, reflecting higher pricing across our route network, strong demand and our acquisitions of Blade Europe and Blade Canada
  • MediMobility Organ Transport revenue up 801% versus the prior year period, driven by the acquisition of new transplant center clients, robust growth with existing clients, and our acquisition of Trinity Air Medical ("Trinity")
  • Flight Profit increased 108% versus the prior year period, driven by growth in all business lines and stronger pricing in our Short Distance business
  • Blade completed our acquisition of the commercial businesses of three of the largest European urban air mobility companies on September 1, 2022 ("Blade Europe")

NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) --  Blade Air Mobility, Inc. (Nasdaq: BLDE, "Blade" or the "Company"), a technology-powered air mobility platform, today announced financial results for the third quarter ended September 30, 2022.

"Blade delivered another record quarter with exceptional performance across all business lines," said Rob Wiesenthal, Blade's Chief Executive Officer. "Our Short Distance business exceeded expectations, driven by higher pricing and improved utilization across our route network, which was further boosted by our acquisitions in Canada and Europe. We remain encouraged by the strong demand indicators we see across our consumer-facing businesses, which, combined with our continued share gains in recession-resistant MediMobility Organ Transport, gives us confidence in our ability to deliver profitable growth even amidst a more uncertain macroeconomic environment."

"Our ability to take pricing in excess of inflation resulted in record Flight Profit this quarter, while our overall Corporate Expenses continue to shrink as a percentage of revenues, demonstrating Blade's clear path to profitability," said Will Heyburn, Blade's Chief Financial Officer. "We also continue to drive operational efficiencies in our acquired businesses by deploying the Blade platform, as evidenced by this quarter's 174% organic revenue growth in our MediMobility Organ Transport division, reflecting Trinity's significantly accelerated expansion, post-acquisition."

"With the closing of our Blade Europe acquisition on September 1, 2022, Blade is now the largest urban air mobility company operating across three continents. We look forward to deploying our brand, technology, and customer service in these geographies to further accelerate our growth and fortify Blade's global presence," said Melissa Tomkiel, Blade's President. "We have also successfully diversified Blade's business, with nearly half of our $133 million in trailing twelve month revenue coming from organ transportation, which benefits from multi-year customer contracts, low marketing costs and demand that is uncorrelated with the overall macroeconomic environment."

Third Quarter Ended September 30, 2022 Financial Highlights

  • Total revenue increased 125% to $45.7 million in the current quarter versus $20.3 million in the prior year period. On a pro forma basis, assuming Blade had owned Trinity, Blade Canada and Blade Europe in the comparable prior year period, revenue for the third quarter ended September 30, 2022 would have increased 60% on a constant currency basis.
  • Flight Profit increased 108% to $9.3 million in the current quarter versus $4.5 million in the prior year period, driven by growth in all business lines and stronger pricing in our Short Distance business.
  • Flight Margin of 20.3% decreased versus 22.0% in the prior year period, as expected, driven primarily by outsized growth in MediMobility Organ Transport, which outpaced that of our other business lines. MediMobility Organ Transport tends to have lower Flight Margin versus our company average, but benefits from long-term customer contracts, no utilization risk, limited marketing costs and demand that is uncorrelated with the overall economic environment. This revenue mix impact was partially offset by stronger pricing in our Short Distance business.
  • Short Distance revenue increased 52% to $20.4 million in the current quarter versus $13.4 million in the prior year period. Growth was driven by improved pricing and utilization across our route network, the closing of our acquisition of Blade Europe on September 1, 2022, our acquisition of Blade Canada, and growth in our Blade Airport service.
  • MediMobility Organ Transport revenue increased 801% to $20.2 million in the current quarter versus $2.2 million in the prior year period, driven by Blade's acquisition of Trinity in September 2021. Revenue increased 17% sequentially in Q3 2022 versus Q2 2022. On a pro forma basis, assuming Blade had owned Trinity in the prior year period, organic revenue growth in MediMobility Organ Transport would have been 174% versus the prior year period, driven by the acquisition of new hospital clients and continued growth with existing accounts.
  • Jet and Other revenue increased 9% to $5.1 million in the current quarter versus $4.7 million in the prior year period driven primarily by an increase in the average price per jet charter trip.
  • Net loss of $9.2 million in the quarter was roughly unchanged versus a net loss of $9.2 million in the prior year period.
  • Adjusted EBITDA decreased to $(4.5) million in the current quarter from $(3.2) million in the prior year period, but improved as a percentage of revenues to (9.9)% in the current quarter from (15.5)% in the prior year period. The increased loss versus the prior year period is primarily attributable to additional corporate and recurring expenses related to Blade's recent growth and expected future growth, partially offset by increased Flight Profit.

Business Highlights and Recent Updates

  • Blade's MediMobility Organ Transport division, which is the largest dedicated air transporter of human organs for transplant in the United States, continues to grow its client base with several new customer additions this quarter and is now serving a total of 67 transplant centers and organ procurement organizations.
  • Blade Airport, offering service between Manhattan and both JFK and Newark Airports, has continued to show sequential improvements, achieving record revenues in October.
  • On September 1, 2022, Blade completed the previously announced acquisitions of the asset-light commercial passenger transport activities of three urban air mobility operators in Europe for a total cash outlay of $48.1 million.
  • Blade expanded our partnership with Eve Air Mobility, Embraer's Electric Vertical Aircraft company, conducting Urban Air Mobility simulations using helicopters in both Chicago and India. Blade and Eve offered flights in Chicago this September and will be piloting service with Blade India in Bangalore this month. The partnership with Blade India also incorporates a non-binding order of up to 200 of Eve's Electric Vertical Aircraft.
  • On October 19, 2022, Melissa Tomkiel, Blade's President, was appointed by the United States Transportation Department to the Federal Aviation Administration Advanced Aviation Advisory Committee, which provides advice on key Advanced Air Mobility and drone issues.

Conference Call

The Company will conduct a conference call starting at 4:30 p.m. ET on Wednesday, November 9, 2022 to discuss the results for the third quarter ended September 30, 2022.

A live audio-only webcast of the call may be accessed from the Investors section of the Company's website at https://ir.blade.com/. An archived replay of the call will be available on the Investor Relations section of the Company's website for one year.

Use of Non-GAAP Financial Information

Blade believes that the non-GAAP measures discussed below, viewed in addition to and not in lieu of our reported U.S. Generally Accepted Accounting Principles ("GAAP") results, provide useful information to investors by providing a more focused measure of operating results, enhance the overall understanding of past financial performance and future prospects, and allow for greater transparency with respect to key metrics used by management in its financial and operational decision making. The non-GAAP measures presented herein may not be comparable to similarly titled measures presented by other companies. Adjusted EBITDA, Flight Profit, Corporate Expenses, Adjusted Corporate Expenses and Pro forma revenue have been reconciled to the nearest GAAP measure in the tables within this press release.

Adjusted EBITDA - Blade reports Adjusted EBITDA, which is a non-GAAP financial measure. This measure excludes non-cash items or certain transactions that are not indicative of ongoing Company operating performance and / or items that management does not believe are reflective of our ongoing core operations (as shown in the table below).

Constant currency - The condensed consolidated interim financial statements included here are presented in U.S. dollars. However, Blade's international operations give rise to fluctuations in foreign exchange rates. To neutralize foreign exchange impact and illustrate the underlying change in revenue from one year to the next, Blade has included results in constant currency. These are calculated by applying the current period exchange rates to local currency reported results for both the current and prior year which excludes any variances attributable to foreign exchange rate movements.

Flight Profit and Flight Margin - Blade defines Flight Profit as revenue less cost of revenue. Blade defines Flight Margin for a period as Flight Profit for the period divided by revenue for the same period.

Corporate Expenses and Adjusted Corporate Expenses - Blade defines Corporate Expenses as total operating expenses excluding cost of revenue. Blade defines Adjusted Corporate Expenses as Corporate Expenses excluding non-cash items or certain transactions that are not indicative of ongoing Company operating performance and / or items that management does not believe are reflective of our ongoing core operations (as shown in the table below).

Pro forma revenue - Blade uses pro forma financial information which include revenue from acquisitions as if they had been acquired in the commensurate period of the prior year. Pro forma change in revenue is calculated as the difference between the current reported revenue and the comparative period pro forma revenue. Management believes that discussing pro forma revenue contributes to the understanding of Blade's performance and trends, because it allows for meaningful comparisons of the current year period to that of prior years.

Financial Results

BLADE AIR MOBILITY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data, unaudited)

 September 30,
2022
 December 31,
2021
Assets   
Current assets:   
Cash and cash equivalents$51,845  $2,595 
Restricted cash 1,139   630 
Accounts receivable 11,271   5,548 
Short-term investments 150,378   279,374 
Prepaid expenses and other current assets 10,773   6,798 
Total current assets 225,406   294,945 
    
Non-current assets:   
Property and equipment, net 2,220   2,045 
Investment in joint venture 390   200 
Intangible assets, net 48,533   24,421 
Goodwill 31,852   13,328 
Operating right-of-use asset 16,944   713 
Other non-current assets 1,312   232 
Total assets$326,657  $335,884 
    
Liabilities and Stockholders' Equity   
Current liabilities:   
Accounts payable and accrued expenses$11,562  $6,369 
Deferred revenue 6,036   5,976 
Operating lease liability, current 2,627   438 
Total current liabilities 20,225   12,783 
    
Non-current liabilities:   
Warrant liability 9,067   31,308 
Operating lease liability, long-term 14,516   278 
Deferred tax liability 144   144 
Total liabilities 43,952   44,513 
    
Stockholders' Equity   
Preferred stock, $0.0001 par value, 2,000,000 shares authorized at September 30, 2022 and December 31, 2021. No shares issued and outstanding at September 30, 2022 and December 31, 2021.     
Common stock, $0.0001 par value; 400,000,000 authorized; 71,506,665 and 70,667,381 shares issued at September 30, 2022 and December 31, 2021, respectively. 7   7 
Additional paid in capital 373,223   368,680 
Accumulated other comprehensive loss (2,262)  (898)
Accumulated deficit (88,263)  (76,418)
Total stockholders' equity 282,705   291,371 
    
Total Liabilities and Stockholders' Equity$326,657  $335,884 


BLADE AIR MOBILITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, unaudited)

 Three Months Ended
September 30,
 Nine Months Ended
September 30,
  2022   2021    2022   2021  
Revenue$45,722  $20,316   $107,985  $42,540  
          
Operating expenses         
Cost of revenue (1) 36,456   15,855    90,685   33,628  
Software development (1) 2,026   844    3,923   1,456  
General and administrative (1) 15,812   12,115    41,934   26,748  
Selling and marketing (1) 1,856   1,231    5,294   2,433  
Total operating expenses 56,150   30,045    141,836   64,265  
          
Loss from operations (10,428)  (9,729)   (33,851)  (21,725) 
          
Other non-operating income (expense)         
Change in fair value of warrant liabilities 425   (3,418)   22,241   (18,331) 
Realized loss from sales of short-term investments (359)      (2,071)    
Recapitalization costs attributable to warrant liabilities    11       (1,731) 
Interest income, net 1,173   309    1,892   453  
Total other non-operating income (expense) 1,239   (3,098)   22,062   (19,609) 
          
Loss before income taxes (9,189)  (12,827)   (11,789)  (41,334) 
          
Income tax expense (benefit) 56   (3,643)   56   (3,643) 
          
Net loss$(9,245) $(9,184)  $(11,845) $(37,691) 

__________
(1) Prior period amounts have been updated to conform to current period presentation.


BLADE AIR MOBILITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)

 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 
  2022   2021    2022   2021   
Cash Flows From Operating Activities:          
Net loss$(9,245) $(9,184)  $(11,845) $(37,691)  
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities:          
Depreciation and amortization 1,441   191    3,741   457   
Stock-based compensation 1,685   3,924    5,627   8,346   
Change in fair value of warrant liabilities (425)  3,418    (22,241)  18,331   
Realized loss from sales of short-term investments 359       2,071      
Realized foreign exchange loss 12       7      
Accretion of interest income on held-to-maturity securities (311)      (311)     
Deferred tax benefit    (3,643)      (3,643)  
Recapitalization costs attributable to warrant liabilities    (11)      1,731   
Loss on disposal of property and equipment 132       197      
Changes in operating assets and liabilities:          
Prepaid expenses and other current assets 121   1,806    (3,781)  (3,940)  
Accounts receivable (337)  206    (4,461)  39   
Other non-current assets 93   (84)   (1,059)  (116)  
Operating right-of-use assets/lease liabilities 90   17    196   35   
Accounts payable and accrued expenses 2,980   (1,819)   4,255   600   
Deferred revenue (2,941)  (612)   (417)  236   
Other (5)  1    (5)  1   
Net cash used in operating activities (6,351)  (5,790)   (28,026)  (15,614)  
           
Cash Flows From Investing Activities:          
Acquisitions, net of cash acquired (48,101)  (23,066)   (48,101)  (23,065)  
Investment in joint venture (190)      (190)     
Purchase of property and equipment (93)  (67)   (719)  (264)  
Purchase of short-term investments (120,036)  (5,609)   (120,489)  (308,772)  
Proceeds from sales of short-term investments 39,677   11,300    248,377   11,300   
Net cash provided by / (used in) investing activities (128,743)  (17,442)   78,878   (320,801)  
           
Cash Flows From Financing Activities:          
Proceeds from the exercise of common stock options 2   120    81   142   
Taxes paid related to net share settlement of equity awards (154)  (52)   (1,165)  (52)  
Proceeds from note payable             
Repayment of note payable          (1,165)  
Proceeds from recapitalization of EIC, net of issuance costs    113       215,101   
Proceeds from sale of common stock in PIPE, net of issuance costs          119,634   
Net cash (used in) / provided by financing activities (152)  181    (1,084)  333,660   
           
Effect of foreign exchange rate changes on cash balances (16)     (9)     
Net (decrease) increase in cash and cash equivalents and restricted cash (135,262)  (23,051)   49,759   (2,755)  
Cash and cash equivalents and restricted cash - beginning 188,246   30,633    3,225   10,337   
Cash and cash equivalents and restricted cash - ending$52,984  $7,582   $52,984  $7,582   
           
Reconciliation to the unaudited interim condensed consolidated balance sheets          
Cash and cash equivalents$51,845  $6,952   $51,845  $6,952   
Restricted cash 1,139   630    1,139   630   
Total$52,984  $7,582   $52,984  $7,582   
Non-cash investing and financing activities          
New leases under ASC 842 entered into during the period$  $   $5,871  $13   

Non-GAAP Financial Information


BLADE AIR MOBILITY, INC.
DISAGGREGATED REVENUE BY PRODUCT LINE
(in thousands, unaudited)

 Three Months Ended
September 30,
 Nine Months Ended
September 30,
  2022  2021   2022  2021 
Product Line(1):         
Short Distance$20,402 $13,403  $35,568 $20,252 
MediMobility Organ Transport 20,219  2,245   50,143  5,130 
Jet and Other 5,101  4,668   22,274  17,158 
Total Revenue$45,722 $20,316  $107,985 $42,540 

__________
(1) Prior period amounts have been updated to conform to current period presentation.


BLADE AIR MOBILITY, INC.
RECONCILIATION OF REVENUE LESS COST OF REVENUE TO FLIGHT PROFIT
(in thousands except percentages, unaudited)

 Three Months Ended
September 30,
 Nine Months Ended
September 30,
  2022   2021    2022   2021  
Revenue$45,722  $20,316   $107,985  $42,540  
Cost of revenue(1) 36,456   15,855    90,685   33,628  
Flight Profit$9,266  $4,461   $17,300  $8,912  
Flight Margin 20.3%  22.0%   16.0%  20.9% 

__________

(1) Cost of revenue consists of flight costs paid to operators of aircraft and cars, landing fees and internal costs incurred in generating ground transportation revenue using the Company's owned cars. Prior period amounts have been updated to conform to current period presentation.


BLADE AIR MOBILITY, INC.
SEATS FLOWN - ALL PASSENGER FLIGHTS
(unaudited)

 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 2022 2021  2022 2021 
Seats flown - all passenger flights(1)28,440 13,897  75,175 22,123 

__________
(1) Prior period amounts have been updated to conform to current period presentation. The 2022 figures do not include seats flown by Blade Europe from the acquisition date through September 30, 2022.


BLADE AIR MOBILITY, INC.
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA
(in thousands, unaudited)

 Three Months Ended
September 30,
 Nine Months Ended
September 30,
  2022   2021    2022   2021  
Net loss$(9,245) $(9,184)  $(11,845) $(37,691) 
          
Depreciation and amortization 1,441   191    3,741   457  
Stock-based compensation 1,685   3,924    5,627   8,346  
Change in fair value of warrant liabilities (425)  3,418    (22,241)  18,331  
Realized loss from sales of short term investments 359       2,071     
Recapitalization costs attributable to warrant liabilities    (11)      1,731  
Interest income, net (1,173)  (309)   (1,892)  (453) 
Consulting costs related to initial public listing    1,417       3,455  
Offering documents expenses    302       626  
Recruiting fees related to initial public listing    235       333  
M&A transaction costs 1,361   510    2,785   590  
One-time legal and regulatory advocacy fees 143       2,054    
Income tax expense (benefit) 56   (3,643)   56   (3,643) 
Short term incentive plan costs recorded in Q3 but related to prior quarters 1,250            
Adjusted EBITDA$(4,548) $(3,150)  $(19,644) $(7,918) 
Adjusted EBITDA as a percentage of Revenue(9.9)% (15.5)%  (18.2)% (18.6)% 


BLADE AIR MOBILITY, INC.
RECONCILIATION OF TOTAL OPERATING EXPENSES TO ADJUSTED CORPORATE EXPENSES
(in thousands except percentages, unaudited)

 Three Months Ended September 30, Nine Months Ended
September 30,
  2022   2021    2022   2021  
Revenue$45,722  $20,316   $107,985  $42,540  
          
Total operating expenses 56,150   30,045    141,836   64,265  
Subtract:         
Cost of revenue (1) 36,456   15,855    90,685   33,628  
Corporate Expenses$19,694  $14,190   $51,151  $30,637  
Corporate Expenses as percentage of Revenue 43%  70%   47%  72% 
Adjustments to reconcile Corporate Expenses to Adjusted Corporate Expenses         
Subtract:         
Depreciation and amortization 1,441   191    3,741   457  
Stock-based compensation 1,685   3,924    5,627   8,346  
Consulting costs related to initial public listing    1,417       3,455  
Offering documents expenses    302       626  
Recruiting fees related to initial public listing    235       333  
M&A transaction costs 1,361   510    2,785   590  
One-time legal and regulatory advocacy fees 143       2,054    
Short term incentive plan costs recorded in Q3 but related to prior quarters 1,250            
Adjusted Corporate Expenses$13,814  $7,611   $36,944  $16,830  
Adjusted Corporate Expenses as percentage of Revenue 30%  37%   34%  40% 

__________
(1) Prior period amounts have been updated to conform to current period presentation.



BLADE AIR MOBILITY, INC.
RECONCILIATION OF REPORTED REVENUE TO PRO FORMA REVENUE
(in thousands except percentages, unaudited)


The following unaudited pro forma financial information presents what our revenue would have been if Trinity and Blade Canada had been acquired and launched, respectively, on January 1, 2021, and if the Blade Europe businesses had been acquired on September 1, 2021.

Three months ended September 30       
 Total Short Distance MediMobility
Organ Transport
 Jet and Other
Reported Revenue three months ended September 30, 2021$20,316  $13,403  $2,245  $4,668 
Impact of Trinity 5,134      5,134    
Impact of Canada 980   980       
Impact of Blade Europe from September 1 2,335   2,335       
Pro forma Revenue$28,765  $16,718  $7,379  $4,668 
        
Reported Revenue three months ended September 30, 2022$45,722  $20,402  $20,219  $5,101 
Pro forma change in revenue 59%  22%  174%  9%
        
Impact of foreign currency translation (1)%   (2)%  **  ** 
Pro forma constant currency change in revenue 60%  24%  174%  9%
** Percentage not applicable       


Nine months ended September 30       
 Total Short Distance MediMobility
Organ Transport
 Jet and Other
Reported Revenue nine months ended September 30, 2021$42,540  $20,252  $5,130  $17,158 
Impact of Trinity 15,129      15,129    
Impact of Canada 1,808   1,808       
Impact of Blade Europe from September 1 2,335   2,335       
Pro forma Revenue$61,812  $24,395  $20,259  $17,158 
        
Reported Revenue nine months ended September 30, 2022$107,985  $35,568  $50,143  $22,274 
Pro forma change in revenue 75%  46%  148%  30%
        
Impact of foreign currency translation (1)%  (2)%  **  ** 
Pro forma constant currency change in revenue 76%  48%  148%  30%
** Percentage not applicable       


BLADE AIR MOBILITY, INC.
LAST TWELVE MONTHS DISAGGREGATED REVENUE BY PRODUCT LINE
(in thousands except percentages, unaudited)

    Three Months Ended
  Last Twelve
Months
 September 30,
2022
 June 30,
2022
 March 31,
2022
 December 31,
2021
Product Line:(1)          
Short Distance $41,823 $20,402 $10,963 $4,203 $6,255
MediMobility Organ Transport  59,965  20,219  17,249  12,675  9,822
Jet and Other  30,815  5,101  7,421  9,752  8,541
Total Revenue $132,603 $45,722 $35,633 $26,630 $24,618

__________
(1) Prior period amounts have been updated to conform to current period presentation.

About Blade Air Mobility

Blade is a technology-powered, global air mobility platform committed to reducing travel friction by providing cost-effective air transportation alternatives to some of the most congested ground routes in the U.S. and abroad. Today, the Company predominantly uses helicopters and amphibious aircraft for its passenger routes and is also one of the largest air medical transporters of human organs for transplant in the world. Its asset-light model, coupled with its exclusive passenger terminal infrastructure, is designed to facilitate a seamless transition to Electric Vertical Aircraft ("EVA" or "eVTOL"), enabling lower cost air mobility to the public that is both quiet and emission-free.

For more information, visit www.blade.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by the use of words such as "will", "anticipate," "believe," "could," "continue," "expect," "estimate," "may," "plan," "outlook," "future" and "project" and other similar expressions and the negatives of those terms. These statements, which involve risks and uncertainties, relate to analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable and may also relate to Blade's future prospects, developments and business strategies. In particular, such forward-looking statements include statements concerning Blade's estimated and future financial and operating performance, results of operations, business strategies and plans, customer behavior, competitive position, industry environment and growth opportunities. These statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance.

Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Blade's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements include: the duration and severity of the COVID-19 pandemic, failure of the markets for our offerings to grow as expected, or at all; our ability to attract and retain customers and increase existing customer utilization rates; the inability or unavailability to use or take advantage of the shift, or lack thereof, to EVA technology or the failure of such technology to deliver the expected results and cost savings; our ability to successfully enter new markets and launch new offerings; accidents or safety-related events involving small aircraft that create adverse publicity; the effects of competition; effects of pricing pressures; injuries to our reputation and brand; challenges to our ability to provide quality customer support at scale; events that cause decreases in our daily aircraft usage rates and flier utilization rates; shifts in customer preferences, discretionary spending and the ability of our customers to pay for our services; disruption of operations at the heliports and airports where our operations are concentrated; risks associated climate change, including potential increased impacts of severe weather and regulatory activity; the availability of aircraft fuel; technology system failures, defects, errors, or vulnerabilities and cyber-based attacks; our ability to receive favorable placements in mobile application marketplaces and effectively operate our mobile operating systems and applications; our ability to protect our intellectual property rights; risks related to our use of open source software; our ability to maintain and expand our facility and infrastructure network; our ability to obtain additional funding on acceptable terms, or at all; our ability to successfully navigate international expansion; our ability to identify, complete and successfully integrate acquisitions; our ability to manage future growth effectively; our ability or that of our third-party operators to obtain sufficient insurance at reasonable cost, or at all; the loss of key members of our management team; disruptions in the operations of our third-party operators, their failure to perform adequately, or their misuse of Blade-branded aircraft; the loss of our existing relationships with third-party operators or our inability to attract and retain qualified new operators to meet demand; disruptions or interference in our use of third-party web services; changes in our regulatory environment, including aviation law and FAA regulations; regulatory obstacles that may block our ability to offer our services in certain jurisdictions on a profitable basis, or at all; our ability to comply with privacy, data protection, consumer protections and environmental laws and regulations and changes to such laws and their interpretations; our ability to remediate any material weaknesses or maintain effective an effective system of disclosure controls and internal control over financial reporting; changes in the fair value of our warrants; and other factors beyond our control. Additional factors can be found in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each as filed with the U.S. Securities and Exchange Commission. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and Blade undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, changes in expectations, future events or otherwise.

Press Contacts
For Media Relations
Lee Gold
press@blade.com

For Investor Relations
Ravi Jani
investors@blade.com


Comeback Aktien - Fünf Top-Werte für Ihr Depot
Jetzt im kostenlosen Report: Schwierige Zeiten an der Börse brauchen starke Aktien. Am besten solche, die auch noch günstig zu haben sind. Börsenprofi Lars Wißler hat fünf Top-Werte für Sie herausgesucht.
© 2022 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.